{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-007172","form_type":"8-K","ticker":"ANIX","cik":"0000715446","company_name":"Anixa Biosciences Inc","filed_at":"2023-03-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:47.849398+00:00","generated_at":"2026-06-18T06:04:02.978072+00:00","sec_items":["5.07","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Anixa Biosciences stockholders re-elect four directors, approve say-on-pay, ratify auditor","bullets":["Re-elected Dr. Amit Kumar (10.26M for, 940k withheld), Dr. Arnold Baskies, Emily Gottschalk, and Lewis H. Titterton Jr.","Non-binding advisory vote on executive compensation passed: 9.17M for, 1.82M against, 221k abstain.","Ratified Haskell & White LLP as auditor for FY ending Oct 31, 2023: 20.44M for, 61k against.","Annual meeting held March 9, 2023; 20.97M shares represented out of 30.92M outstanding."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-007172","json":"https://secwatch.observer/filing/0001493152-23-007172.json","markdown":"https://secwatch.observer/filing/0001493152-23-007172.md","text":"https://secwatch.observer/filing/0001493152-23-007172.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/715446/000149315223007172/0001493152-23-007172-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/715446/000149315223007172/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T06:04:02.978072+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0539f1fd8cdf40def7b8c1ea460bdb538bdb388a","claim":"Anixa Biosciences Inc shareholders approved Election of directors at the 2023-03-09 meeting.","evidence_excerpt":"Proposal No. 1 – Election of directors Dr. Amit Kumar, Dr. Arnold Baskies, Emily Gottschalk, and Lewis H. Titterton, Jr. were each re-elected to serve until the 2024 annual meeting of stockholders or until their successors are elected and qualified or until their earlier resignation or removal. The voting results were as follows: Nominee Shares Voted For Shares Withheld Broker Non-Vote Dr. Amit Kumar 10,263,393 940,600 9,765,865 Dr. Arnold Baskies 10,273,898 930,095 9,765,865 Emily Gottschalk 10,055,355 1,148,638 9,765,865 Lewis H. Titterton, Jr. 9,825,204 1,378,789 9,765,865","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/715446/000149315223007172/0001493152-23-007172-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-03-09"}],"fact_type":"shareholder_vote"},{"claim_id":"61af9e057e2f3f4a703de1ef3b6e6224dcbe1d88","claim":"Anixa Biosciences Inc shareholders approved Ratification of the appointment of independent registered public accounting firm at the 2023-03-09 meeting.","evidence_excerpt":"Proposal No. 3 – Ratification of the appointment of independent registered public accounting firm The appointment of Haskell & White LLP as the Company’s independent registered public accounting firm for the fiscal year ending October 31, 2023 was ratified. The voting results were as follows: Shares Voted For Shares Voted Against Shares Abstaining Broker Non-Vote 20,439,779 61,616 468,463 -","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/715446/000149315223007172/0001493152-23-007172-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-03-09"}],"fact_type":"shareholder_vote"},{"claim_id":"63af8a8ddb090234c01927de266022408bf922db","claim":"Anixa Biosciences Inc shareholders approved Approval, by non-binding advisory vote, of the Company's executive compensation at the 2023-03-09 meeting.","evidence_excerpt":"Proposal No. 2 – Approval, by non-binding advisory vote, of the Company’s executive compensation The Company’s executive compensation, by non-binding advisory vote, was approved. The voting results were as follows: Votes For Votes Against Abstentions Broker Non-Votes 9,166,107 1,816,322 221,564 9,765,865","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/715446/000149315223007172/0001493152-23-007172-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-03-09"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}